Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine β-hydroxylase

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2468-2476

  Thomas, Steven A ^a,c   Marck, Brett T ^b   Palmiter, Richard D ^a   Matsumoto, Alvin M ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dihydroxyphenylserine; Dopamine; Dopamine hydroxylase; Epinephrine; Mice; Norepinephrine

Indexed keywords

ADRENALIN; AMINO ACID DECARBOXYLASE; CARBIDOPA; DOPAMINE BETA MONOOXYGENASE; NORADRENALIN; THREO 3,4 DIHYDROXYPHENYLSERINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME DEFECT; ENZYME INHIBITION; GENE TARGETING; MALE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERTANT;

ANIMALIA;

EID: 0031745285     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062468.x     Document Type: Article

References (28)

1. Armando I. and Barontini M. (1995) Function and significance of the renal Dopa/DA system. Acta Physiol. Pharmacol. Ther. Latinoam. 45, 135-146.
2. Barnes C. D. and Pompeiano O., eds (1991) Progress in Brain Research, Vol. 88: Neurobiology of the Locus Coeruleus. Elsevier, London.
3. Benkert O., Gluba H., and Matsussek N. (1973) Dopamine, nor-adrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-Dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine. Neuropharmacology 12, 177-186.
4. Biaggioni I. and Robertson D. (1987) Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet ii, 1170-1172.
5. Biaggioni I., Goldstein D. S., Atkinson T., and Robertson D. (1990) Dopamine β-hydroxylase deficiency in humans. Neurology 40, 370-373.
6. Creveling C. R., Daly J., Tokuyama T., and Witkop B. (1968) The combined use of alpha-methyl-tyrosine and threo-DOPS - selective reduction of dopamine levels in the CNS. Biochem. Pharmacol. 17, 65-70.
7. Kato T., Katsuyama M., Karai N., Hirose A., Nakamura M., and Katsube J. (1986) Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxyphenylserine (L-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialimide. Naunyn Schmiedebergs Arch. Pharmacol. 332, 243-246.
8. Kato T., Karai N., Katsuyama M., Nakamura M., and Katsube J. (1987a) Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Biochem. Pharmacol. 36, 3051-3057.
9. Kato T., Katsuyama M., Karai N., Nakamura M., and Katsube J. (1987b) Studies on the central action of L-threo-3,4-dihydroxyphenylserine (L-DOPS) in FLA-63-treated mice. Pharmacol. Biochem. Behav. 26, 407-411.
10. Landsberg L. and Young J. B. (1992) Catecholamines and the adrenal medulla, in Williams Textbook of Endocrinology, 8th edit. (Wilson J. D. and Foster D. W., eds), pp. 621-705. W. B. Saunders, Philadelphia.
11. Langley K. (1994) The neuroendocrine concept today. Ann. NY Acad. Sci. 94, 1-17.
12. Levi-Montalcini R. and Angeletti P. U. (1966) Immunosympathectomy. Pharmacol. Rev. 18, 619-628.
13. Man in 't Veld A. J., Boomsma F., van den Meiracker A. H., and Schalekamp M. A. D. H. (1987) Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase deficiency. Lancet ii, 1172-1175.
14. Mason S. T. and Fibiger H. C. (1979) Physiological function of descending noradrenaline projections to the spinal cord: role in post-decapitation convulsions. Eur. J. Pharmacol. 57, 29-34.
15. Mathias C. J., Bannister R. B., Cortelli P., Heslop K., Polak J. M., Raimbach S., Springall D. R., and Watson L. (1990) Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline from dopamine because of a deficiency of dopamine beta hydroxylase. Q. J. Med. 75, 617-633.
16. Mogilnicka E., Dooley D. J., Boissard C. G., and Delini-Stula A. (1983) Altered hindlimb extension in the rat after DSP-4: a useful marker of central noradrenergic depletion. Eur. J. Pharmacol. 87, 345-347.
17. Nicholls D. G. and Locke R. M. (1984) Thermogenic mechanisms in brown fat. Physiol. Rev. 64, 1-64.
18. Oliverio A. and Stjärne L. (1965) Acceleration of noradrenaline turnover in the mouse heart by cold exposure. Life Sci. 4, 2339-2343.
19. Pearse A. G. E. (1974) The APUD cell concept and its implications in pathology. Pathol. Annu. 9, 27-42.
20. Pendleton R. G., Snow I. B., Gessner G., and Green H. (1973) Studies on the turnover and synthesis of epinephrine from norepinephrine in the adrenal gland. Arch. Int. Pharmacodyn. Ther. 203, 368-375.
21. Saari M., Ings R., and Pappas B. A. (1978) Ontogeny of the post-decapitation convulsion in the rat: effects of neonatal systemic 6-hydroxydopamine. Neuropharmacology 17, 873-877.
22. Svensson T. H. (1971) On the role of central norepinephrine in the regulation of motor activity and body temperature in the mouse. Naunyn Schmiedebergs Arch. Pharmacol. 271, 111-120.
23. Tafari A. T., Thomas S. A., and Palmiter R. D. (1997) Norepinephrine facilitates the development of the murine sweat response but is not essential. J. Neurosci. 17, 4275-4281.
24. Thomas S.A. and Palmiter R. D. (1997a) Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline and adrenaline. Nature 387, 94-97.
25. Thomas S. A. and Palmiter R. D. (1997b) Disruption of the dopamine β-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning and memory. Behav. Neurosci. 111, 579-589.
26. Thomas S. A. and Palmiter R. D. (1997c) Impaired maternal behavior in mice lacking norepinephrine and epinephrine. Cell 91, 583-592.
27. Thomas S. A., Matsumoto A. M., and Palmiter R. D. (1995) Noradrenaline is essential for mouse fetal development. Nature 374, 643-646.
28. Zhou Q.-Y. and Palmiter R. D. (1995) Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83, 1197-1209.